These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21114898)

  • 1. Evaluation of factors associated with recruitment in hematological clinical trials: a retrospective cohort study.
    Lemieux J; Amireault C; Camden S; Poulin J
    Hematology; 2010 Dec; 15(6):373-7. PubMed ID: 21114898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of eligibility and recruitment in breast cancer clinical trials.
    Lemieux J; Forget G; Brochu O; Provencher L; Cantin G; Desbiens C; Doyle C; Poirier B; Camden S; Durocher M
    Breast; 2014 Aug; 23(4):385-92. PubMed ID: 24679829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer-based screening of patients with HIV/AIDS for clinical-trial eligibility.
    Carlson RW; Tu SW; Lane NM; Lai TL; Kemper CA; Musen MA; Shortliffe EH
    Online J Curr Clin Trials; 1995 Mar; Doc No 179():[3347 words; 32 paragraphs]. PubMed ID: 7719564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying barriers associated with enrollment of patients with lung cancer into clinical trials.
    Horn L; Keedy VL; Campbell N; Garcia G; Hayes A; Spencer B; Carbone DP; Sandler A; Johnson DH
    Clin Lung Cancer; 2013 Jan; 14(1):14-8. PubMed ID: 22591607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment.
    Filion M; Forget G; Brochu O; Provencher L; Desbiens C; Doyle C; Poirier B; DuRocher M; Camden S; Lemieux J
    Clin Trials; 2012 Oct; 9(5):652-9. PubMed ID: 23060323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of selection criteria on recruitment in an interventional stroke trial.
    Hotter B; Jegzentis K; Steinbrink J; Schmidt WU; Endres M; Meisel A; Haverkamp W; Jungehulsing GJ
    Cerebrovasc Dis; 2013; 36(5-6):344-50. PubMed ID: 24192450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformity between protocol eligibility criteria for electronic patient identification: a comparison of clinical trials.
    Kamauu A; Agbor S; Kamauu A
    Stud Health Technol Inform; 2013; 192():1167. PubMed ID: 23920941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cancer care and protocol characteristics associated with recruitment in breast cancer clinical trials.
    Lemieux J; Goodwin PJ; Pritchard KI; Gelmon KA; Bordeleau LJ; Duchesne T; Camden S; Speers CH
    J Clin Oncol; 2008 Sep; 26(27):4458-65. PubMed ID: 18802158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands.
    van den Bogert CA; Souverein PC; Brekelmans CTM; Janssen SWJ; Koëter GH; Leufkens HGM; Bouter LM
    J Clin Epidemiol; 2017 Aug; 88():140-147. PubMed ID: 28487159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tool support for authoring eligibility criteria for cancer trials.
    Rubin DL; Gennari JH; Srinivas S; Yuen A; Kaizer H; Musen MA; Silva JS
    Proc AMIA Symp; 1999; ():369-73. PubMed ID: 10566383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log.
    Hunter CP; Frelick RW; Feldman AR; Bavier AR; Dunlap WH; Ford L; Henson D; Macfarlane D; Smart CR; Yancik R
    Cancer Treat Rep; 1987 Jun; 71(6):559-65. PubMed ID: 3581095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding appropriate clinical trials: evaluating encoded eligibility criteria with incomplete data.
    Ash N; Ogunyemi O; Zeng Q; Ohno-Machado L
    Proc AMIA Symp; 2001; ():27-31. PubMed ID: 11825151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALS clinical trials: do enrolled patients accurately represent the ALS population?
    Chiò A; Canosa A; Gallo S; Cammarosano S; Moglia C; Fuda G; Calvo A; Mora G;
    Neurology; 2011 Oct; 77(15):1432-7. PubMed ID: 21956723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of participation of patients in cancer clinical trials in Ireland.
    Morris PG; Kelly R; Horgan A; Nasim S; Kehily D; Grogan L; Breathnach OS
    Ir J Med Sci; 2007 Sep; 176(3):153-6. PubMed ID: 17619093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital.
    Ho J; Pond GR; Newman C; Maclean M; Chen EX; Oza AM; Siu LL
    BMC Cancer; 2006 Nov; 6():263. PubMed ID: 17092349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials.
    Kornblith AB; Kemeny M; Peterson BL; Wheeler J; Crawford J; Bartlett N; Fleming G; Graziano S; Muss H; Cohen HJ;
    Cancer; 2002 Sep; 95(5):989-96. PubMed ID: 12209681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial analysis of patients with newly diagnosed acute myelogenous leukemia on protocol or standard therapy.
    Berman E; Little C; Teschendorf B; Jones M; Heller G
    Cancer; 2002 Sep; 95(5):1064-70. PubMed ID: 12209692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of DRG for identifying clinical trials centers with high recruitment potential: a feasability study.
    Aegerter P; Bendersky N; Tran TC; Ropers J; Taright N; Chatellier G
    Stud Health Technol Inform; 2014; 205():783-7. PubMed ID: 25160294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing clinical trials in older people.
    Carroll CB; Zajicek JP
    Maturitas; 2011 Apr; 68(4):337-41. PubMed ID: 21376485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging Real-World Data for the Selection of Relevant Eligibility Criteria for the Implementation of Electronic Recruitment Support in Clinical Trials.
    Melzer G; Maiwald T; Prokosch HU; Ganslandt T
    Appl Clin Inform; 2021 Jan; 12(1):17-26. PubMed ID: 33440429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.